increased demands of the fetus in pregnancy. Deficiencies in these micronutrients can lead to increased maternal adiposity, maternal and offspring insulin resistance and adverse lipid profile in neonates. This review aims to assess existing evidence linking maternal vitamin B12 deficiency with obesity.
Results: Of 366 articles identified, seven met inclusion criteria. Most studies were observational, with one case control study. There was consistent evidence linking maternal obesity with low vitamin B12 levels (defined as <150 pmol/L).
Most studies adjusted for potential confounders, such as maternal demographics, lifestyle factors, pregnancy related factors and hemodilution. BMI remained a significant negative predictor of low vitamin B12.
In the case control study, third trimester vitamin B12 insufficiency was associated with a 2.4 times increased odds of first trimester obesity.
Conclusions:
As the prevalence of maternal obesity is rapidly increasing, the implications of low vitamin B12 on maternal and fetal health need to be considered. Further longitudinal cohort studies are needed to understand the mechanisms between vitamin B12 and obesity, to identify any possible causal relationship and therefore potentially offer simple interventions to improve maternal and offspring health. Objectives: To quantify actograph output in healthy third trimester pregnancies and investigate this in relation to estimated fetal weight.
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Methods: 42 women between 24 to 34 weeks of gestation underwent an ultrasound growth scan followed by a computerised cardiotocograph (CTG). Post capture analysis of the actograph recording was performed and expressed as a percentage of activity over time. The actograph output results were analysed in relation to estimated fetal weight (Hadlock) based on ultrasound and expressed as z score normalised for gestation.
Results: There was a significant association between actograph output recording and estimated fetal weight Z score (R = 0.546, p = <0.005). This activity was not related to estimated fetal weight.
Conclusions:
Fetal movements assessed by the actograph are associated with fetal size in relation to gestation. It is not the case that larger babies move more, however, as the relationship with actograph output related only to estimated fetal weight z score. Previous studies have suggested that optimal fetal size for perinatal survival is between the 80-90th centiles. Hence, average birthweight may not be associated with optimal fetal and perinatal health. If fetal movements are understood to be a marker of fetal health, then smaller babies that move less maybe at particular perinatal risk.
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Pregnancy outcome of presentation with reduced fetal movements (RFM) to day assessment unit Objectives: The perception of FM is a natural, symbolic involvement of the mother in the growth of a fetus, promoting maternal-fetal bonding. RFM has association with complications such as IUGR, fetal distress, stillbirth and admission to NICU. Monitoring of fetal movement is therefore a useful and inexpensive screening tool for fetal wellbeing. Perception of RFM is very subjective and affected by maternal factors such as raised BMI, maternal activities and maternal medications. Evaluation of the attendance with outcome of patients with RFM is essential for provision of holistic care. Methods: A retrospective study was carried out on sample of pts presenting to DAU of RBH Reading with RFM focusing on the following outcome; gestation of presentation (GP), gestation of delivery(GD), mode of delivery, APGAR score and cord gases. Results: 180 pt presented at DAU with RFM out of 924 pts' visitation over a 6-wk period.
61(6.6%) pts were followed up for the pregnancy outcome. % of Pt & GP:
• 20-26wks-(6.5%). 27-31wks-(26.2%). 32-36wks-(24.6%). 37-40wks-(21.3%) • % of Pt & GD;-• <30wks; -1.6% {EMCS}, • 31-36wks; -6.6%{1-SVD,2-FD,1-EMCS}, • 37-40wks; -42.6%{SVD-15, FD-6 C/section -5),
• 40-42wks; -47.5%{SVD-15 FD-5 C/section-9}
Only one patient who presented at 29wks with emergency Caesarean section has both low APGAR and low arterial PH of 7.07venous 7.08 BE -11. Conclusions: Pt with RFM makes up 19.6% of presentations. Majority presented at 32-36wk (24.6%) follow by 37-40wks (21.3%). RFM < 30wks gestation which necessitates delivery is likely to result in EMCS with low APGAR and Blood Gases.
Pt with Hx of RFM that delivered between 31 -36wks have 75% chances of vaginal delivery (50% instrumental delivery) and 25% chance of Caesarean section. While those delivering between 37-40wks have 80% vaginal delivery chances and 19%-Caesarean section.
Pt delivering between 40-42wks have 31% chances of Caesarean section, 69% of Vagina delivery (17% instrumental delivery) This study has limitation of involvement of small number and variation in maternal perception of RFM.
This study also showed an association with maternal BMI and perception of RFM.
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Evaluation of self-testing of urine by patient during pregnancy F. Ajibade, S. Agwu
Obstetrics and Gynecology, Worcester Royal Hospital, Worcester, United Kingdom
Objectives: Testing of urine is important for diagnosis of pregnancy and monitoring of women health during antenatal period
